Roche takes aim at Illumina's dominance with new gene sequencing machine

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...
Devdiscourse

Roche's Axelios: Shaking Up the Gene Sequencing Market

Roche has launched its Axelios gene sequencing machine, aiming to challenge Illumina's dominance in the genetic-testing ...
Wall Street Journal

Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion

Roche Holding struck a deal with Nurix Therapeutics NRIX1.96%increase; up pointing triangle to license an experimental blood-cancer drug for up to $2.3 billion, expanding its pipeline in oncology and ...
Wall Street Journal

Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools

Roche Holding ROP0.25%increase; up pointing triangle said it agreed to buy PathAI for up to $1.05 billion in a deal that seeks to bolster the artificial-intelligence offerings of its diagnostics ...
Bloomberg L.P.

Roche Expects Blockbuster Cancer Pill Launch by Year End

Roche Holding AG expects to launch the breast cancer pill that may become one of its biggest sellers by the end of the year, sparking optimism about its prospects. The medicine, called giredestrant, ...
Forbes

Roche Bought Thousands Of Nvidia AI Chips To Speed Up Drug Development

It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...
STAT

Roche moves obesity drug to pivotal trials after mid-stage success

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Roche plans to launch Phase 3 ...
Barron's

Roche Sets Gene-Sequencing Record. It’s a Challenge for Illumina.

This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...
CNBC

Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial

Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player. The drugmaker's CT-388 weight loss injection is entering a phase III trial, marking the ...
Bloomberg L.P.

Roche May Sell Drugs Directly in US to Bypass Middlemen

Roche Holding AG is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer. The Swiss drugmaker has discussed ...
The Indianapolis Star

Roche will put $550 million facility for glucose monitors in Indianapolis, adding 650 jobs

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further solidify ...
MedCity News

Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...